Professional Profile
Dr. Bob Nordyke is a Vice President and Senior Policy Advisor in the BlueRidge Life Sciences Pharmaceutical Commercialization practice. With over 25 years in the health sciences and pharma industry, Dr. Nordyke is an experienced executive leader and deep practitioner of health economics, policy research, health technology assessment (HTA) and value assessment, and product commercialization. Dr. Nordyke specializes in identifying opportunities to increase value in healthcare systems and communicating evidence to demonstrate that value to multiple stakeholders. He utilizes rigorous scientific methodology, commercial strategy, business development, and leadership to craft innovative solutions for today’s complex market access challenges.
Before joining BlueRidge, Dr. Nordyke worked as a principal, advisor, and vice president at a variety of manufacturers, health policy associations, and product value strategy consultancies, founding or leading their health economics and access strategy groups. He has successfully integrated health economic principles with expertise in pricing, payer marketing, and commercialization to deliver tailored solutions to clients’ development and commercialization programs.
Dr. Nordyke has authored or co-authored numerous papers in the peer reviewed literature on health economics, policy, and value assessment topics. In addition, he has served as a lecturer at the USC Sol Price School of Public Policy and as an adjunct professor at the UCLA Fielding School of Public Health.